Health in Tech (HIT): CEO received 2M shares
Sanjay K Shrestha, CEO at Health in Tech, reported a grant / award of 2M shares.
- 2M
- Shares
- Traded
- Oct 20, 2026
- Filed
- Oct 23, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Sep 9, 2026InsiderDirector sold ~$5.3K of HIT shares in the open market
- Sep 11, 2026Insider · 2 peopleInsiders: 2 sales (~$22K)
- Sep 14, 2026InsiderDirector sold ~$11K of HIT shares in the open market
- Oct 12, 2026Company filing · Form 8-K · Listing noticeReceived a notice from its stock exchange“On October 14, 2026, Health In Tech, Inc. (the “Company”) received a letter from the Listing Qualifications Department (the “Nasdaq Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of the resignation of Sanjay Shrestha from the Board of Directors of the Company (the “Board”) and the Audit Committee of the Board (the “Audit Committee”) on August 10, 2026, as was previously…”
- Oct 16, 2026InsiderOfficer sold ~$2.1K of HIT shares in the open market
- Oct 20, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On October 20, 2026, the Board of Directors (the “Board”) of Health In Tech, Inc. (the “Company” or “Health In Tech”) appointed Sanjay Shrestha to serve as the Chief Executive Officer of the Company, effective as of such date (the “Effective Date”).”
What came next
- Nov 2, 2026Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- Nov 3, 2026InsiderOfficer sold ~$917 of HIT shares in the open market
- Nov 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
- Nov 18, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“As previously disclosed in a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on November 12, 2026 and in the Quarterly Report on Form 10-Q for the quarter ended September 30, 2026 filed with the SEC on November 13, 2026, respectively, the stockholders of Health In Tech, Inc., a Nevada corporation (the “Company”), elected Tim Cortes, age 60, to the Company’s Board of…”
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Health in Tech
For Health in Tech, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HIT page.
How this filing works
Explore the data
Common questions
Which Health in Tech (HIT) insider traded, and how much?
Sanjay K Shrestha, CEO at Health in Tech, reported a grant / award of 2M shares. Not an open-market trade.
When did it happen, and when was it made public?
Traded: Oct 20, 2026. Filed: Oct 23, 2026. That is 3 days between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Health in Tech recently?
For Health in Tech, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the HIT page.
Does this mean HIT stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Health in Tech
- SEC Form 4Nov 5, 2026
- SEC Form 4Oct 19, 2026
- SEC Form 4Sep 15, 2026
- SEC Form 4Sep 14, 2026
- SEC Form 4Sep 12, 2026
- SEC Form 4Sep 12, 2026
Everything OQRO holds on this company is on its HIT page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
